Systemic Lupus Erythematosus

Systemic lupus erythematosus is an autoimmune disorder which can affect and damage any organ system in the body. It has a diverse range of immunological manifestations and is more prominent in young women, with the exact etiology still unknown. Here is the latest research on systemic lupus erythematosus.

September 27, 2020

Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease

Inflammatory Bowel Diseases
Preetika Sinh, Raymond Cross
September 26, 2020
Open Access

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy

Frontiers in Immunology
Cecilia Beatrice ChighizolaFrancesco Tedesco
September 27, 2020

The role of TASL in the pathogenesis of SLE: X marks the spot

Annals of the Rheumatic Diseases
David S Pisetsky
September 26, 2020

Bacterial infections in a pediatric cohort of primary and acquired complement deficiencies

Pediatric Rheumatology Online Journal
Taha Al-ShaikhlyEric J Allenspach
September 29, 2020
Open Access

Epitranscriptomic N4-Acetylcytidine Profiling in CD4+ T Cells of Systemic Lupus Erythematosus

Frontiers in Cell and Developmental Biology
Gangqiang GuoXiangyang Xue
September 29, 2020

The Immune Regulatory Effect of Boron on Ostrich Chick Splenic Lymphocytes

Biological Trace Element Research
Xiaoting ZhangKemei Peng
September 27, 2020

Basophils and Systemic Lupus Erythematosus in Murine Models and Human Patients

Kuanysh DossybayevaDimitri Poddighe
September 26, 2020
Open Access

Requisite Omega-3 HUFA Biomarker Thresholds for Preventing Murine Lupus Flaring

Frontiers in Immunology
Kathryn A WierengaJames J Pestka
September 29, 2020

Understanding Lupus Disparities Through a Social Determinants of Health Framework: The Georgians Organized Against Lupus Research Cohort

Rheumatic Diseases Clinics of North America
S Sam Lim, Cristina Drenkard
September 26, 2020

A case of systemic lupus erythematosus/systemic sclerosis overlap syndrome successfully treated with belimumab

European Journal of Dermatology : EJD
Mami HaraMasashi Akiyama
September 26, 2020
Open Access

Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis

Therapeutic Advances in Musculoskeletal Disease
Liying PengXiaofeng Zeng
September 25, 2020

Human marginal zone B cell development from early T2 progenitors

BioRxiv : the Preprint Server for Biology
T. J. TullJo Spencer
September 26, 2020

Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay

Translational Research : the Journal of Laboratory and Clinical Medicine
Yvonne SundströmLouise Berg
September 29, 2020

Health Disparities in Systemic Lupus Erythematosus

Rheumatic Diseases Clinics of North America
Christine A Peschken

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

© 2020 Meta ULC. All rights reserved